Key issues in prevention and treatment of peritoneal metastatic gastric cancer

doi:10.16139/j.1007-9610.2021.01.001

Abstract

CLC Number:

R735.2

ZHU Zhenggang. Key issues in prevention and treatment of peritoneal metastatic gastric cancer[J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 1-6.

References 38

[1]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[2]	曹毛毛, 陈万青. 中国恶性肿瘤流行情况及防控现状[J]. 中国肿瘤临床, 2019, 46(3):145-149.
[3]	朱正纲. 胃癌腹膜转移综合治疗的若干进展[J]. 中华实验外科杂志, 2015, 32(9):2039-2041.
[4]	朱正纲. 胃癌腹膜转移转化性治疗的临床意义和实践要点[J]. 中华胃肠外科杂志, 2017, 20(10):1094-1098.
[5]	Nashimoto A, Akazawa K, Isobe Y, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry[J]. Gastric Cancer, 2013, 16(1):1-27. doi: 10.1007/s10120-012-0163-4 pmid: 22729699
[6]	de Andrade JP, Mezhir JJ. The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review[J]. J Surg Oncol, 2014, 110(3):291-297. doi: 10.1002/jso.23632 pmid: 24850538
[7]	Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma[J]. Br J Surg, 2000, 87(2):236-242.
[8]	Tanaka T, Kumagai K, Shimizu K, et al. Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement; extranodal invasion is a significant risk factor for peritoneal metastasis[J]. J Surg Oncol, 2000, 75(3):165-171. pmid: 11088047
[9]	Huang B, Sun Z, Wang ZN, et al. Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database[J]. BMC Cancer, 2013, 13:57.
[10]	Lee JH, Son SY, Lee CM, et al. Factors predicting peritoneal recurrence in advanced gastric cancer: implication for adjuvant intraperitoneal chemotherapy[J]. Gastric Cancer, 2014, 17(3):529-536.
[11]	中国抗癌协会胃癌专业委员会. 胃癌腹膜转移防治中国专家共识[J]. 中华胃肠外科杂志, 2017, 20(5):481-490.
[12]	Lavonius MI, Gullichsen R, Salo S, et al. Staging of gastric cancer: a study with spiral computed tomography, ultrasonography, laparoscopy, and laparoscopic ultrasonography[J]. Surg Laparosc Endosc Percutan Tech, 2002, 12(2):77-81.
[13]	NCCN Clinical Practice Guidelines in Oncology-Gastric Cancer(Version 1.2019)[EB/OL]. [2020-12-03]. https://www.nccn.org.
[14]	Hu YE, Deng ZW, Liu H, et al. Staging laparoscopy improves treatment decision-making for advanced gastric cancer[J]. World J Gastroenterol, 2016, 22(5):1859-1868.
[15]	Bottcher KA, Kraemer SJM, Feussner H, et al. Laparoscopic diagnosis of peritoneal carcinoma in gastric cancer[M]//Yutaka Yonemura. Peritoneal dissemination-Mole-cular mechanisms and the latest therapy. Kanazawa, Japan: Maeda Shoten, 1998:147-152.
[16]	李进, 秦叔逵, 马军, 等. 胃癌诊疗指南2019-中国临床肿瘤学会(CSCO)常见恶性肿瘤诊疗指南2019[M]. 北京: 人民卫生出版社, 2019:199-240.
[17]	Wang FH, Shen L, Li J, et al. The Chinese Society of Clinical Oncology(CSCO): clinical guidelines for the diag-nosis and treatment of gastric cancer[J]. Cancer Commun(Lond), 2019, 39(1):10-40.
[18]	Beeharry MK, Ni ZT, Yang ZY, et al. Study protocol of a multicenter phase Ⅲ randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastriccancer (AGC): dragon Ⅱ trial[J]. BMC Cancer, 2020, 20:224-232.
[19]	朱正纲, 汤睿, 燕敏, 等. 术中腹腔内温热化疗对进展期胃癌的临床疗效研究[J]. 中华胃肠外科杂志, 2006, 9(1):26-30.
[20]	Zhu ZG, Tang R, Yan M, et al. Efficacy and safety of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer patients with serosal invasion. A long-term follow-up study[J]. Dig Surg, 2006, 23(1-2):93-102.
[21]	Beeharry MK, Zhu ZL, Liu WT, et al. Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study[J]. BMC Cancer, 2019, 19(1):932-941
[22]	Beeharry MK, Zhu ZL, Liu WT, et al. Correction to: prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study[J]. BMC Cancer, 2019, 19(1):1256.
[23]	詹宏杰, 梁寒, 王宝贵, 等. 60例进展期胃癌术中腹腔热灌注化疗的临床观察[J]. 中国肿瘤临床, 2010, 37(4):229-231.
[24]	倪震天, 李琛, 严超, 等. 手术联合术中腹腔温热化疗治疗进展期胃癌疗效及安全性 Meta分析[J]. 中华胃肠外科杂志, 2016, 19(12):1406-1413.
[25]	Kwon OK, Chung HY, Yu W. Early postoperative intraperitoneal chemotherapy for macroscopically serosa-invading gastric cancer patients[J]. Cancer Res Treat, 2014, 46(3):270-279.
[26]	朱正纲. 进展期胃癌围手术期治疗全程管理的若干要点[J]. 中华胃肠外科杂志, 2020, 23(2):115-122.
[27]	Sugarbaker PH, 杨智冉, 李雁. 国际腹膜癌治疗指南:肿瘤细胞减灭术加腹腔化疗临床路径[J]. 中国肿瘤临床, 2020, 47(11):541-551.
[28]	Glehen O, Gilly FN, Arvieux C, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy[J]. Ann Surg Oncol, 2010, 17(9):2370-2377.
[29]	Rihuete Caro C, Manzanedo I, Pereira F, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis[J]. Eur J Surg Oncol, 2018, 44(11):1805-1810.
[30]	Brandl A, Yonemura Y, Glehen O, et al. Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: a multi-institutional cohort from PSOGI[J]. Eur J Surg Oncol, 2021, 47(1):172-180.
[31]	Bonnot PE, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis[J]. J Clin Oncol, 2019, 37(23):2028-2040.
[32]	Desiderio J, Chao J, Melstrom L, et al. The 30-year experience-a meta-analysis of randomized and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer[J]. Eur J Cancer, 2017, 79:1-14 doi: S0959-8049(17)30868-7 pmid: 28456089
[33]	Yonemura Y, Ishibashi H, Hirano M, et al. Effects of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy and neoadjuvant intraperitoneal/systemic chemotherapy on peritoneal metastases from gastric cancer[J]. Ann Surg Oncol, 2017, 24(2):478-485. doi: 10.1245/s10434-016-5487-6 pmid: 27506661
[34]	Yamaguchi H, Kitayama J, Ishigami H, et al. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis[J]. Cancer, 2013, 119(18):3354-3358. doi: 10.1002/cncr.28204 pmid: 23798046
[35]	Ishigami H, Fujiwara Y, Fukushima R, et al. Phase Ⅲ trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial[J]. J Clin Oncol, 2018, 36(19):1922-1929.
[36]	Solass W, Kerb R, Mürdter T, et al. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressu-rized aerosol as an alternative to liquid solution: first evidence for efficacy[J]. Ann Surg Oncol, 2014, 21(2):553-559.
[37]	Alyami M, Hübner M, Grass F, et al. Pressurised intraperitoneal aerosol chemotherapy: rational, evidence, and potential indications[J]. Lancet Oncol, 2019, 20(7):e368-e377.
[38]	Chia DKA, So JBY. Recent advances in intra-peritoneal chemotherapy for gastric cancer[J]. J Gastric Cancer, 2020, 20(2):115-126.

Key issues in prevention and treatment of peritoneal metastatic gastric cancer

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 38

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	YAN Chao, LU Sheng, YAN Min, ZHU Zhenggang. Chinese interpretation of Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition) and Ruijin clinical practice [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 326-354.
[2]	SUN Qi, HUANG Wenbo, HE Bingliang, LIU Chang, XU Yuhang, ZHAO Wei. Efficacy with prognostic value of postoperative prophylactic hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 366-370.
[3]	SUN Qiang, YAO Jun, ZHANG Xin, DU Shanshan, WANG Weijun. Research progress of anti reflux digestive tract reconstruction for proximal gastrectomy [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 388-393.
[4]	YAN Su, ZHENG Minhua. Practice of single-port and reduced-port laparoscopic gastric cancer surgery in China [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 233-239.
[5]	HU Wenqing, YANG Yinhao, CUI Peng, WEI Wei. Current status of high-positioned digestive tract reconstruction after laparoscopic proximal stomach and lower esophagus resection through the abdominal-left diaphragmatic approach for adenocarcinoma of esophagogastric junction [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 226-232.
[6]	FAN Qingquan, SONG Xiaoling, GU Jun. Exosome in gastric cancer: research and perspective [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 177-180.
[7]	DENG Shijie, YUAN Fei. Advances in diagnosis and molecular detection of EBV-positive gastric cancer and gastric cancer with lymphoid stroma [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 53-57.
[8]	ZHANG Huan, CHEN Yong. New progression of radiomics in diagnosis of gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 42-48.
[9]	LIU Wentao, LIU Fukun. Summary and prospect of perioperative comprehensive treatment for gastric cancer in China [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 36-41.
[10]	LI Guoli, GUO Feilong. Preoperative chemotherapy through intra-arterial combined with intra-venous administration in treatment of advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 31-35.
[11]	ZHAO Fazhi, ZHAO Ping. Formation and improvement of surgery-based treatment system for gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 24-30.
[12]	LU Yiming, XIONG Jianping, TIAN Yantao. Current status and prospect of conversion therapy for far-advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 17-23.
[13]	LI Jianfang, YU Junxian, YAN Chao, ZHU Zhenggang, LIU Bingya. Hotspots in basic and translational research of gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 7-16.
[14]	ZHU Zhenggang. Progress and prospect of surgical comprehensive treatment of gastric cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 1-6.
[15]	LUO Xi, SHI Yongmei, CHEN Ke, JIANG Shuo, WU Yuwei. Analysis on evaluation of patients with gastric and colon cancer using modified patient-generated subjective global assessment [J]. Journal of Surgery Concepts & Practice, 2022, 27(06): 545-550.